药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Hexobarbital
Bemiparin
The risk or severity of bleeding can be increased when Bemiparin is combined with Nintedanib.
Hexobarbital
Dextran
The risk or severity of bleeding can be increased when Dextran is combined with Nintedanib.
Hexobarbital
Sodium citrate
The risk or severity of bleeding can be increased when Sodium citrate is combined with Nintedanib.
Hexobarbital
Potassium citrate
The risk or severity of bleeding can be increased when Potassium citrate is combined with Nintedanib.
Hexobarbital
Ditazole
The risk or severity of bleeding can be increased when Ditazole is combined with Nintedanib.
Hexobarbital
Triflusal
The risk or severity of bleeding can be increased when Triflusal is combined with Nintedanib.
Hexobarbital
Nadroparin
The risk or severity of bleeding can be increased when Nadroparin is combined with Nintedanib.
Hexobarbital
Ethyl biscoumacetate
The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Nintedanib.
Hexobarbital
(R)-warfarin
The risk or severity of bleeding can be increased when (R)-warfarin is combined with Nintedanib.
Hexobarbital
Ferulic acid
The risk or severity of bleeding can be increased when Ferulic acid is combined with Nintedanib.
Hexobarbital
Tinzaparin
The risk or severity of bleeding can be increased when Tinzaparin is combined with Nintedanib.
Hexobarbital
Dalteparin
The risk or severity of bleeding can be increased when Dalteparin is combined with Nintedanib.
Hexobarbital
Danaparoid
The risk or severity of bleeding can be increased when Danaparoid is combined with Nintedanib.
Hexobarbital
Amediplase
The risk or severity of bleeding can be increased when Amediplase is combined with Nintedanib.
Hexobarbital
Otamixaban
The risk or severity of bleeding can be increased when Otamixaban is combined with Nintedanib.
Hexobarbital
Astaxanthin
The risk or severity of bleeding can be increased when Astaxanthin is combined with Nintedanib.
Hexobarbital
Cangrelor
The risk or severity of bleeding can be increased when Cangrelor is combined with Nintedanib.
Hexobarbital
Idraparinux
The risk or severity of bleeding can be increased when Idraparinux is combined with Nintedanib.
Hexobarbital
Semuloparin
The risk or severity of bleeding can be increased when Semuloparin is combined with Nintedanib.
Hexobarbital
Sulodexide
The risk or severity of bleeding can be increased when Sulodexide is combined with Nintedanib.